"Breakthrough Gene Therapy Offers Hope for Hereditary Angioedema"

A groundbreaking gene therapy has shown promising results in treating hereditary angioedema, a rare disorder causing painful and potentially fatal swelling. Patients in the trial experienced dramatic improvements, with some being able to come off long-term medication and return to normal life. The therapy, using Crispr gene editing, aims to provide a permanent cure by targeting the genetic mutation causing the condition. While larger trials are ongoing, the high cost of one-shot gene therapies may limit accessibility, but the results offer hope for a potential cure for some sufferers.